We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-13.86%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.39B
AUM Growth
+$23.5M
Cap. Flow
+$245M
Cap. Flow %
17.64%
Top 10 Hldgs %
24.95%
Holding
4,841
New
999
Increased
1,367
Reduced
1,469
Closed
908

Sector Composition

Rank Sector Weight
1 Healthcare 6.26%
2 Financials 5.86%
3 Technology 5.03%
4 Energy 4.85%
5 Consumer Discretionary 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPAS
1726
DELISTED
Ipass Inc Common Stock
IPAS
$27K ﹤0.01%
14,452
+2,903
+25% +$5.02K
ANGO icon
1727
AngioDynamics
ANGO
$649M
$26K ﹤0.01%
1,270
+1,170
+1,170% +$24.2K
APYX icon
1728
Apyx Medical
APYX
$171M
$26K ﹤0.01%
+3,974
New +$24.1K
AVXL icon
1729
Anavex Life Sciences
AVXL
$310M
$26K ﹤0.01%
16,572
+3,205
+24% +$7.28K
CAKE icon
1730
Cheesecake Factory
CAKE
$5.33B
$26K ﹤0.01%
603
-5,564
-90% -$270K
CHMI
1731
Cherry Hill Mortgage Investment Corp
CHMI
$88.5M
$26K ﹤0.01%
+1,499
New +$27.4K
DHC
1732
Diversified Healthcare Trust
DHC
$2.14B
$26K ﹤0.01%
2,210
-22,602
-91% -$335K
GLAD icon
1733
Gladstone Capital
GLAD
$446M
$26K ﹤0.01%
1,792
+1,609
+879% +$28.3K
HCKT icon
1734
Hackett Group
HCKT
$287M
$26K ﹤0.01%
+1,664
New +$31K
HEFA icon
1735
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.71B
$26K ﹤0.01%
+1,000
New +$27.8K
ICAD
1736
DELISTED
iCAD Inc
ICAD
$26K ﹤0.01%
6,929
+1,686
+32% +$5.56K
IGSB icon
1737
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
$26K ﹤0.01%
511
-180
-26% -$9.28K
ING icon
1738
ING
ING
$102B
$26K ﹤0.01%
+2,436
New +$29.3K
LTC
1739
LTC Properties
LTC
$2.15B
$26K ﹤0.01%
623
+420
+207% +$18.4K
PFIS icon
1740
Peoples Financial Services
PFIS
$707M
$26K ﹤0.01%
+577
New +$24.5K
RF icon
1741
Regions Financial
RF
$26.8B
$26K ﹤0.01%
1,983
-1,376
-41% -$22.1K
SILC icon
1742
Silicom
SILC
$242M
$26K ﹤0.01%
744
+661
+796% +$25.8K
SRPT icon
1743
Sarepta Therapeutics
SRPT
$1.77B
$26K ﹤0.01%
237
+7
+3% +$875
STR
1744
DELISTED
Sitio Royalties
STR
$26K ﹤0.01%
759
-4,340
-85% -$155K
TEX icon
1745
Terex
TEX
$7.74B
$26K ﹤0.01%
957
-9,335
-91% -$298K
UG icon
1746
United-Guardian
UG
$33.5M
$26K ﹤0.01%
1,395
+796
+133% +$13.7K
VRNT
1747
DELISTED
Verint Systems
VRNT
$26K ﹤0.01%
+1,221
New +$28.1K
WSBF icon
1748
Waterstone Financial
WSBF
$375M
$26K ﹤0.01%
1,581
-1,134
-42% -$18.8K
TBNK
1749
DELISTED
Territorial Bancorp Inc.
TBNK
$26K ﹤0.01%
+1,012
New +$28K
ICPT
1750
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$26K ﹤0.01%
259
+160
+162% +$16.6K

Similar funds

Tower Research Capital (TRC)'s Q4 2018 Portfolio in Review

As of Q4 2018, Tower Research Capital (TRC) held 4,841 positions worth $1.39B, up 1.7% from $1.36B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $245M of net new capital in Q4 2018, opening 999 new positions and adding to 1,367 existing holdings. Its largest new stake was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.

By sector, the portfolio is most concentrated in Healthcare at 6.3% of assets, down from 6.8% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $124M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2018 buy was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2018, an estimated $123M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $124M.
  • Tower Research Capital (TRC) fully exited State Street Energy Select Sector SPDR ETF in Q4 2018, selling an estimated $26.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.39B portfolio in Q4 2018.
  • Tower Research Capital (TRC) opened 999 new positions and closed 908 in Q4 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 1.7% quarter-over-quarter to $1.39B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2018, filed 14 Feb 2019.